Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

C. Gridelli(Instituto Tecnológico de Ciudad Madero), Vittorio Gebbia(Università degli Studi di Enna Kore)
JNCI Journal of the National Cancer Institute
March 4, 2003
10.1093/jnci/95.5.362
Cited by 795

Related Papers

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Author Index Vol. 77, Suppl. 1, 2009
|Oncology|2009|0